General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-25 | 2024-03 | 0.61 | N/A | N/A | N/A |
2024-02-08 | 2023-12 | 0.86 | 0.88 | 0.02 | 2.33% |
2023-11-02 | 2023-09 | 0.66 | 0.68 | 0.02 | 3.03% |
2023-07-27 | 2023-06 | 0.59 | 0.55 | -0.04 | -6.78% |
2023-04-27 | 2023-03 | 0.48 | 0.59 | 0.11 | 22.92% |
2023-02-09 | 2022-12 | 0.94 | 0.88 | -0.06 | -6.38% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-20 | Citigroup | Upgrade | Neutral | Neutral |
2023-07-31 | Barclays | Upgrade | Overweight | Overweight |
2023-07-30 | Keybanc | Upgrade | Overweight | Overweight |
2023-07-30 | Barclays | Upgrade | Overweight | Overweight |
2023-07-27 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-07-11 | Stifel | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-05 | ALMEIDA JOSE E. | Chief Executive Officer | 569.90K | Stock Award(Grant) |
2024-03-05 | BORZI JAMES W | Officer | 67.74K | Stock Award(Grant) |
2024-03-05 | GRADE JOEL T. | Chief Financial Officer | 96.62K | Stock Award(Grant) |
2024-03-05 | KNIGHT HEATHER | Officer | 160.33K | Stock Award(Grant) |
2024-03-05 | MASON JEANNE K | Officer | 188.48K | Stock Award(Grant) |
2024-03-05 | RASUL REAZ | Officer | 109.19K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 65.17M | 2.97B | 12.87% |
2023-06-29 | Vanguard Group Inc | 60.64M | 2.76B | 11.98% |
2023-06-29 | State Street Corporation | 21.51M | 979.97M | 4.25% |
2023-06-29 | Price (T.Rowe) Associates Inc | 15.25M | 694.97M | 3.01% |
2023-06-29 | Geode Capital Management, LLC | 10.63M | 484.27M | 2.10% |
2023-06-29 | Ameriprise Financial, Inc. | 9.74M | 443.65M | 1.92% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 15.75M | 717.77M | 3.11% |
2023-06-29 | Vanguard 500 Index Fund | 12.04M | 548.72M | 2.38% |
2023-06-29 | Vanguard Mid-Cap Index Fund | 11.72M | 533.84M | 2.31% |
2023-07-30 | Blackrock Equity Dividend Fund | 10.51M | 475.59M | 2.08% |
2023-05-30 | Fidelity 500 Index Fund | 5.65M | 229.96M | 1.12% |
2023-08-30 | SPDR S&P 500 ETF Trust | 5.55M | 225.48M | 1.10% |
Dividend | Date |
---|---|
0.29 | 2024-03-01 |
0.29 | 2024-02-29 |
0.29 | 2023-11-30 |
0.29 | 2023-08-31 |
0.29 | 2023-06-01 |
0.29 | 2023-02-23 |
Split | Date |
---|---|
1.84128 : 1 | 2015-07-01 |
2 : 1 | 2001-05-31 |
100000 : 90823 | 1992-12-01 |
2 : 1 | 1983-11-18 |
2 : 1 | 1981-11-09 |
35C
$BAX I can proudly say my broker is one of the best manager Karen J Adams in Crypto market, I invested $500 and I made $5,810 after 7days of trade. Message her to be your guidance about trading she is on What'sApp +𝟏𝟖𝟏𝟐𝟐𝟕𝟎𝟔𝟖𝟎𝟕
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on TELEGRAM ᏦᎪᎡᎬΝ Ꭻ ᎪᎠᎪᎷՏ or WhatsApp +❶❽❶❷❷❼⓿❻❽⓿❼
How many knew that Ocugen had a partnership which contractually GUARANTEES them revenues from Covid19 Antibody Testing?
(re: page 22 of annual report):
https://www.sec.gov/Archives/edgar/data/1372299/000110465920053502/tm2017927-1_10ka.htm
Collaboration with Advaite, Inc.
In April 2020, the Company entered into an agreement with Advaite, Inc., (Advaite) to provide certain support services for Advaite's development of a diagnostic test kit that is designed to detect antibodies to COVID-19. ...{Ocugen}... will receive tiered royalty payments based on cumulative net sales of the test kit.
The projected market for Covid diagnostic testing is $61B AND GROWING!
MORE IMPORTANTLY Advaite is NOW MOVING on Covid Antibody Testing!
https://www.linkedin.com/mwlite/company/advaite
*
The BEAUTY here:
NOBODY KNOWS Ocugen will be collecting potentially BILLION$ in COVID DIAGNOSTICS revenue! They NEVER did a PRESS RELEASE!